A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome

被引:39
|
作者
Blumkin, Lubov [2 ]
Kivity, Sara [2 ]
Lev, Dorit [2 ,3 ,4 ]
Cohen, Sarit [1 ]
Shomrat, Ruth [5 ]
Lerman-Sagie, Tally [2 ,4 ]
Leshinsky-Silver, Esther [1 ,2 ,4 ]
机构
[1] Wolfson Med Ctr, Mol Genet Lab, Holon, Israel
[2] Wolfson Med Ctr, Metab Neurogenet Clin, Holon, Israel
[3] Wolfson Med Ctr, Genet Inst, Holon, Israel
[4] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
[5] Pronto Diagnost Ltd, Tel Aviv, Israel
关键词
Opsoclonus-myoclonus-ataxia; Exomics; KCTD7; Corticosteroid treatment; EPILEPSY;
D O I
10.1007/s00415-012-6545-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in the potassium channel-related gene KCTD7 were described so far in a single family with progressive myoclonus epilepsy. We describe a unique phenotype: acute onset of myoclonus and ataxia, associated with abnormal opsoclonus-like eye movements; improvement of clinical symptoms under steroid treatment; and appearance of epileptic activity on EEG 2 years later without overt seizures. After excluding possible genetic causes, whole-genome exome sequencing was performed in order to identify the causative gene. One heterozygous missense mutation (R84W) was detected by exome sequencing and a large heterozygous deletion of exons 3 and 4 by MLPA analysis. The father is heterozygous for the R84W mutation and the mother is heterozygous for the exon 3+4 deletion. The mutation affects a highly conserved segment of the predicted protein, changing a basic amino acid into neutral. The large deletion probably results in a truncated protein. The different phenotype broadens the spectrum of KCTD7-related diseases. Therefore, patients diagnosed as having opsoclonus-myoclonus with an atypical course should be evaluated for KCTD7 mutations.
引用
收藏
页码:2590 / 2598
页数:9
相关论文
共 5 条
  • [1] A COMPOUND HETEROZYGOUS MISSENSE MUTATION AND A LARGE DELETION IN THE KCTD7 GENE PRESENTING AS AN OPSOCLONUS-MYOCLONUS ATAXIA-LIKE SYNDROME
    Blumkin, L.
    Kivity, S.
    Lev, D.
    Leshinsky-Silver, E.
    Lerman-Sagie, T.
    EPILEPSIA, 2012, 53 : 39 - 39
  • [2] A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome
    Lubov Blumkin
    Sara Kivity
    Dorit Lev
    Sarit Cohen
    Ruth Shomrat
    Tally Lerman-Sagie
    Esther Leshinsky-Silver
    Journal of Neurology, 2012, 259 : 2590 - 2598
  • [3] A case of a 6-year-old girl with a rare compound heterozygous mutation of KCTD7 presenting with progressive myoclonic epilepsy
    Reza Shervin Badv
    Fakhreddin Shariatmadari
    Shiva Bayat
    Sara Memarian
    Samaneh Esteghamat Hanzae
    Hossein Yousefimanesh
    Egyptian Journal of Medical Human Genetics, 25 (1)
  • [4] Compound Heterozygous CHAT Gene Mutations of a Large Deletion and a Missense Variant in a Chinese Patient With Severe Congenital Myasthenic Syndrome With Episodic Apnea
    Liu, Zhimei
    Zhang, Li
    Shen, Danmin
    Ding, Changhong
    Yang, Xinying
    Zhang, Weihua
    Li, Jiuwei
    Deng, Jie
    Gong, Shuai
    Liu, Jun
    Qian, Suyun
    Fang, Fang
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [5] A compound heterozygosity of a large deletion and a missense variant in PNPLA6 causing Boucher-Neuhauser syndrome in elderly patients presenting with chronic progressive ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism
    Kalkoljuck, Pannaporn
    Iemwimangsa, Nareenart
    Klumsathian, Sommon
    Panthan, Bhakbhoom
    Termsarasab, Pichet
    Sriphrapradang, Chutintorn
    Sujirakul, Tharikarn
    Chareonsirisuthigul, Takol
    Trachoo, Objoon
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 540 - 541